Kirsten Grønbæk

Kirsten Grønbæk

Clinical Professor

Member of:

  • Internal Medicine: Haematology


  1. Published

    Cell‐of‐origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B‐cell lymphoma

    Abdulla, M., Hollander, P., Pandzic, T., Mansouri, L., Ednersson, S. B., Andersson, P., Hultdin, M., Fors, M., Erlanson, M., Degerman, S., Petersen, H. M., Asmar, F., Grønbæk, Kirsten, Enblad, G., Cavelier, L., Rosenquist, R. & Amini, R., 2020, In: American Journal of Hematology. 95, 1, p. 57-67

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Lenalidomide-bendamustine-rituximab in untreated mantle cell lymphoma > 65 years with untreated mantle cell lymphoma

    Albertsson-Lindblad, A., Kolstad, A., Laurell, A., Räty, R., Grønbæk, Kirsten, Sundberg, J., Pedersen, L. B., Ralfkiær, E., Karjalainen-Lindsberg, M., Sundström, C., Ehinger, M., Geisler, C. & Jerkeman, M., 2016, In: Blood. 128, 14, p. 1814-1820

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Loss of the KN Motif and AnKyrin Repeat Domain 1 (KANK1) Leads to Lymphoid Compartment Dysregulation in Murine Model

    Almosailleakh, M., Bentivegna, Sofia, Narcisi, S., Benquet, Sébastien Jean, Gillberg, Linn, Montaño-Almendras, C. P., Savickas, S., Schoof, E. M., Wegener, A., Luche, H., Jensen, Henrik Elvang, Côme, Christophe Roger Michel & Grønbæk, Kirsten, 2023, In: Genes. 14, 10, 1947.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Lack of somatic mutations in the catalytic domains of CREBBP and EP300 genes implies a role for histone deacetylase inhibition in myeloproliferative neoplasms

    Andersen, Christen Bertel L, Grønbæk, Kirsten & Hasselbalch, Hans Carl, 1 Apr 2012, In: Leukemia Research. 36, 4, p. 485-487 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

    Andersen, C. L., Bjørn, M. E., McMullin, M. F., Harrison, C., Samuelsson, J., Ejerblad, E., Zweegman, S., Fernandes, S., Bareford, D., Knapper, S., Löfvenberg, E., Linder, O., Andreasson, B., Ahlstrand, E., Jensen, M. K., Bjerrum, O. W., Vestergaard, H., Larsen, H., Klausen, T. W., Mourits-Andersen, T. & 5 others, Skov, V., Thomassen, M., Kruse, T., Grønbæk, Kirsten & Hasselbalch, H. C., Jul 2014, In: Leukemia Research. 38, 7, p. 816-821 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome

    Andersen, Christen Bertel L, Nielsen, H. M., Sommer Kristensen, L., Helbo, A. S., Vikeså, J., Jønson, L., Nielsen, Finn Cilius, Hasselbalch, Hans Carl, Bjerrum, O. W., Punj, V. & Grønbæk, Kirsten, 2015, In: OncoTarget. 6, 38, p. 40588-97 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations

    Aslan, D., Garde, C., Nygaard, M. K., Helbo, A. S., Dimopoulos, K., Hansen, Jakob Werner, Severinsen, M. T., Treppendahl, M. B., Sjö, Lene Dissing, Grønbæk, Kirsten & Sommer Kristensen, L., 2016, In: OncoTarget. 7, 9, p. 9951-63 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Methylation and hydroxymethylation in cancer

    Asmar, F., Gillberg, Linn & Grønbæk, Kirsten, 2023, Epigenetic Cancer Therapy [Second Edition]. 2. ed. Elsevier, p. 11-37 27 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

  9. Published

    Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma

    Asmar, F., Punj, V., Christensen, J. A., Pedersen, M. T., Pedersen, A., Nielsen, A. B., Hother, C., Ralfkiaer, U., Brown, Peter de Nully, Ralfkiaer, E., Helin, K. & Grønbæk, Kirsten, Dec 2013, In: Haematologica. 98, 12, p. 1912-20 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another “double hit” lymphoma with very poor outcome?

    Asmar, F., Hother, C., Kulosman, G., Treppendahl, M. B., Nielsen, H. M., Ralfkiaer, U., Pedersen, A., Møller, M. B., Ralfkiaer, E., de Nully Brown, P. & Grønbæk, Kirsten, 15 Apr 2014, In: OncoTarget. 5, 7, p. 1912-25 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...17 Next

ID: 37722667